Parkinson’s Disease Treatment Market Size, Share & Trends Analysis Report By Drug Class (Carbidopa-levodopa, Anticholinergics), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy), By Region, And Segment Forecasts, 2022 - 2030
This report can be delivered to the clients within 4 Business Days
Parkinson’s Disease Treatment Market Growth & Trends
The global Parkinson’s disease treatment market size is expected to reach USD 11.98 billion by 2030, according to a new report by Grand View Research, Inc., growing at a CAGR of 12.1% from 2022 to 2030. This can be attributed to the rising investment in the research and development of novel treatments for PD. In August 2021, the Parkinson’s Foundation announced an investment of USD 43 million as a research grant to 29 research projects having the goal of developing novel treatments and therapies for PD. In addition, in May 2021, the Parkinson’s Foundation announced an investment of USD 10 million for research, care, and educational programs related to Parkinson’s Disease (PD). This investment may aid in providing awareness and genetic testing free of cost to people suffering from PD.
Such investment initiatives are expected to boost industry growth. In the last ten years, there have been significant R&D activities in the PD therapy sector, leading to the development of innovative drug-delivery methods. Due to fewer side effects, these cutting-edge drug delivery systems outperform the existing ones. In addition, the rate of prescription for these techniques has increased due to a rise in patient compliance, which is fueling the expansion of the industry. Moreover, key pharmaceutical companies are undertaking initiatives, such as collaborations and partnerships, for the development, manufacturing & commercialization of products to meet the rising demand for disease treatment in the international market.
For instance, in November 2021, STADA Arzneimittel and Bioglan formed a partnership to expand the production capacity of the medicine Lecigon (levodopa/carbidopa/entacapone) used to treat patients with PD. Thus, increasing demand for medicines that are used to treat patients with PD is anticipated to drive industry growth. However, the limited availability of neurologists leads to issues, such as longer waiting times for patients and difficulty in hiring new neurosurgeons in hospitals. In addition, some of the currently practicing neurologists avoid accepting new Medicaid patients, which creates difficulty for patients who want to switch to another doctor. According to the American Academy of Neurology (AAN) report, around 19% shortage of neurologists is projected by 2025.
Parkinson’s Disease Treatment Market Report Highlights
Parkinson’s Disease Treatment Market Growth & Trends
The global Parkinson’s disease treatment market size is expected to reach USD 11.98 billion by 2030, according to a new report by Grand View Research, Inc., growing at a CAGR of 12.1% from 2022 to 2030. This can be attributed to the rising investment in the research and development of novel treatments for PD. In August 2021, the Parkinson’s Foundation announced an investment of USD 43 million as a research grant to 29 research projects having the goal of developing novel treatments and therapies for PD. In addition, in May 2021, the Parkinson’s Foundation announced an investment of USD 10 million for research, care, and educational programs related to Parkinson’s Disease (PD). This investment may aid in providing awareness and genetic testing free of cost to people suffering from PD.
Such investment initiatives are expected to boost industry growth. In the last ten years, there have been significant R&D activities in the PD therapy sector, leading to the development of innovative drug-delivery methods. Due to fewer side effects, these cutting-edge drug delivery systems outperform the existing ones. In addition, the rate of prescription for these techniques has increased due to a rise in patient compliance, which is fueling the expansion of the industry. Moreover, key pharmaceutical companies are undertaking initiatives, such as collaborations and partnerships, for the development, manufacturing & commercialization of products to meet the rising demand for disease treatment in the international market.
For instance, in November 2021, STADA Arzneimittel and Bioglan formed a partnership to expand the production capacity of the medicine Lecigon (levodopa/carbidopa/entacapone) used to treat patients with PD. Thus, increasing demand for medicines that are used to treat patients with PD is anticipated to drive industry growth. However, the limited availability of neurologists leads to issues, such as longer waiting times for patients and difficulty in hiring new neurosurgeons in hospitals. In addition, some of the currently practicing neurologists avoid accepting new Medicaid patients, which creates difficulty for patients who want to switch to another doctor. According to the American Academy of Neurology (AAN) report, around 19% shortage of neurologists is projected by 2025.
Parkinson’s Disease Treatment Market Report Highlights
- By drug class, the Carbidopa-Levodopa segment held the largest revenue share in 2021 due to the high prevalence of PD and easy drug availability for the disease treatment%li%The retail pharmacy distribution channel segment dominated the global industry in 2021
- This is due to the easy availability of PD drugs in well-established retail pharmacy chains including Walgreens and Walmart
- Asia Pacific is expected to be the fastest-growing region during the forecast period due to the entry of new products into the market
- In June 2020, Ono Pharmaceutical Co., Ltd. received manufacturing and marketing approval for Ongentys to treat patients with PD in Japan
CHAPTER 1 METHODOLOGY AND SCOPE
1.1 Market Segmentation and Scope
1.1.1 Segment scope
1.1.2 Regional scope
1.1.3 Estimates and forecast timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased database:
1.3.2 GVR’s internal database
1.3.3 Secondary sources
1.3.4 Primary research
1.3.5 Details of primary research
1.4 Information or Data Analysis
1.4.1 Data analysis models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis
1.6.1.1 Approach: Commodity Flow Approach
1.7 Research Assumptions
1.8 List of Secondary Sources
1.9 List of Abbreviations
1.10 Objectives
1.10.1 Objective
1.10.2 Objective
1.10.3 Objective
CHAPTER 2 EXECUTIVE SUMMARY
2.1 Market Outlook
CHAPTER 3 PARKINSON’S DISEASE TREATMENT MARKET VARIABLES, TRENDS, AND SCOPE
3.1 Parent Market Outlook
3.1.1 Central Nervous System Therapeutics Market
3.2 Penetration and Growth Prospect Mapping
3.3 Regulatory & Reimbursement Scenario
3.4 Market Driver Analysis
3.4.1 Increasing prevalence of Parkinson’s disease
3.4.2 Presence of strong pipeline drugs
3.4.3 Introduction of novel drug delivery systems
3.5 Market Restraint Analysis
3.5.1 High treatment cost
3.5.2 Lack of neurologist and neurosurgeons
3.6 Major Deals and Strategic Alliances
3.7 Pipeline Analysis
3.8 SWOT Analysis, by Factor (Political & Legal, Economic, and Technological)
3.9 Industry Analysis - Porter’s
CHAPTER 4 PARKINSON’S DISEASE TREATMENT MARKET: COMPETITIVE ANALYSIS
4.1 Recent Developments and Impact Analysis, by Key Market Participants
4.1.1 New Product Launches
4.1.2 Mergers and Acquisitions
4.1.3 Partnerships and Strategic Collaboration
4.1.4 Conferences and Campaigns
4.2 Company Categorization
4.2.1 Innovators
4.2.2 Market Leaders
4.2.3 Heat map analysis
4.3 Vendor Landscape
4.3.1 List of key distributors and channel partners
4.3.2 Key customers
4.4 Key Company Market Share Analysis, 2021
4.5 Public Companies
4.5.1 Company market position analysis
4.5.2 Competitive dashboard analysis
4.5.2.1 Market Differentiators
4.6 Private Companies
4.6.1 List of key emerging companies
4.6.2 Regional Network Map
CHAPTER 5 PARKINSON’S DISEASE TREATMENT MARKET: SEGMENT ANALYSIS, BY DRUG CLASS, 2018 - 2030 (USD MILLION)
5.1 Parkinson’s Disease Treatment Market: Drug Class Movement Analysis
5.2 Carbidopa-Levodopa
5.2.1 Carbidopa-levodopa market, 2018 - 2030 (USD Million)
5.3 Dopamine Agonists
5.3.1 Dopamine agonists market, 2018 - 2030 (USD Million)
5.4 MAO-B Inhibitors
5.4.1 MAO-B inhibitors market, 2018 - 2030 (USD Million)
5.5 COMT inhibitors
5.5.1 COMT inhibitors market, 2018 - 2030 (USD Million)
5.6 Anticholinergics
5.6.1 Anticholinergics market, 2018 - 2030 (USD Million)
5.7 Others
5.7.1 Others market, 2018 - 2030 (USD Million)
CHAPTER 6 PARKINSON’S DISEASE TREATMENT MARKET: SEGMENT ANALYSIS, BY DISTRIBUTION CHANNEL, 2018 - 2030 (USD MILLION)
6.1 Parkinson’s Disease Treatment Market: Distribution Channel Movement Analysis
6.2 Hospital Pharmacy
6.2.1 Hospital pharmacy market, 2018 - 2030 (USD Million)
6.3 Retail Pharmacy
6.3.1 Retail pharmacy market, 2018 - 2030 (USD Million)
6.4 Online Pharmacy
6.4.1 Online pharmacy market, 2018 - 2030 (USD Million)
CHAPTER 7 PARKINSON’S DISEASE TREATMENT MARKET: SEGMENT ANALYSIS, BY REGION, 2018 - 2030 (USD MILLION)
7.1 Definition & Scope
7.2 Regional Market Share Analysis, 2021 & 2030
7.3 Regional Market Snapshot
7.4 Market Size, & Forecasts, Revenue and Trend Analysis, 2021 to 2030
7.4.1 North America
7.4.1.1 North America Parkinson’s disease treatment, 2018-2030 (USD Million)
7.4.1.2 U.S.
7.4.1.2.1 U.S. Parkinson’s disease treatment market, 2018 - 2030 (USD Million)
7.4.1.3 Canada
7.4.1.3.1 Canada Parkinson’s disease treatment market, 2018 - 2030 (USD Million)
7.4.2 Europe
7.4.2.1 Europe Parkinson’s disease treatment market, 2018 - 2030 (USD Million)
7.4.2.2 U.K.
7.4.2.2.1 U.K. Parkinson’s disease treatment market, 2018 - 2030 (USD Million)
7.4.2.3 Germany
7.4.2.3.1 Germany Parkinson’s disease treatment market, 2018 - 2030 (USD Million)
7.4.2.4 Spain
7.4.2.4.1 Spain Parkinson’s disease treatment market, 2018 - 2030 (USD Million)
7.4.2.5 France
7.4.2.5.1 France Parkinson’s disease treatment market, 2018 - 2030 (USD Million)
7.4.2.6 Italy
7.4.2.6.1 Italy Parkinson’s disease treatment market, 2018 - 2030 (USD Million)
7.4.3 Asia Pacific
7.4.3.1 Asia Pacific Parkinson’s disease treatment market, 2018 - 2030 (USD Million)
7.4.3.2 Japan
7.4.3.2.1 Japan Parkinson’s disease treatment market, 2018 - 2030 (USD Million)
7.4.3.3 China
7.4.3.3.1 China Parkinson’s disease treatment market, 2018 - 2030 (USD Million)
7.4.3.4 India
7.4.3.4.1 India Parkinson’s disease treatment market, 2018 - 2030 (USD Million)
7.4.3.5 South Korea
7.4.3.5.1 South Korea Parkinson’s disease treatment market, 2018 - 2030 (USD Million)
7.4.3.6 Australia
7.4.3.6.1 Australia Parkinson’s disease treatment market, 2018 - 2030 (USD Million)
7.4.4 Latin America
7.4.4.1 Latin America Parkinson’s disease treatment market, 2018 - 2030 (USD Million)
7.4.4.2 Brazil
7.4.4.2.1 Brazil Parkinson’s disease treatment market, 2018 - 2030 (USD Million)
7.4.4.3 Mexico
7.4.4.3.1 Mexico Parkinson’s disease treatment market, 2018 - 2030 (USD Million)
7.4.4.4 Argentina
7.4.4.4.1 Argentina Parkinson’s disease treatment market, 2018 - 2030 (USD Million)
7.4.5 MEA
7.4.5.1 MEA Parkinson’s disease treatment market, 2018 - 2030 (USD Million)
7.4.5.2 South Africa
7.4.5.2.1 South Africa Parkinson’s disease treatment market, 2018 - 2030 (USD Million)
7.4.5.3 Saudi Arabia
7.4.5.3.1 Saudi Arabia Parkinson’s disease treatment market, 2018 - 2030 (USD Million)
7.4.5.4 UAE
7.4.5.4.1 UAE Parkinson’s disease treatment market, 2018 - 2030 (USD Million)
CHAPTER 8 PARKINSON’S DISEASE TREATMENT MARKET: COMPANY PROFILES
8.1 Company Profiles
8.1.1 Cerevel Therapeutics
8.1.1.1 Company Overview
8.1.1.2 Financial Performance
8.1.1.3 Product Benchmarking
8.1.1.4 recent Developments
8.1.2 Novartis AG
8.1.2.1 Company Overview
8.1.2.2 Financial Performance
8.1.2.3 Product Benchmarking
8.1.2.4 Recent Developments
8.1.3 Teva Pharmaceutical Industries Ltd
8.1.3.1 Company Overview
8.1.3.2 Financial Performance
8.1.3.3 Product Benchmarking
8.1.3.4 Recent Developments
8.1.4 Merck & Co., Inc.
8.1.4.1 Company Overview
8.1.4.2 Financial Performance
8.1.4.3 Product Benchmarking
8.1.4.4 Recent Developments
8.1.5 GlaxoSmithKline plc. (GSK)
8.1.5.1 Company Overview
8.1.5.2 Financial Performance
8.1.5.3 Product Benchmarking
8.1.5.4 Recent Developments
8.1.6 AbbVie, Inc.
8.1.6.1 Company Overview
8.1.6.2 Financial Performance
8.1.6.3 Product Benchmarking
8.1.6.5 Recent Developments
8.1.7 H. Lundbeck A/S
8.1.7.1 Company Overview
8.1.7.2 Financial Performance
8.1.7.3 Product Benchmarking
8.1.8 Amneal Pharmaceuticals LLC.
8.1.8.1 Company Overview
8.1.8.3 Financial Benchmarking
8.1.8.4 Product Benchmarking
8.1.8.5 Recent Developments
8.1.9 Supernus Pharmaceuticals, Inc.
8.1.9.1 Company Overview
8.1.9.2 Financial performance
8.1.9.3 Product Benchmarking
8.1.9.4 Recent Developments
1.1 Market Segmentation and Scope
1.1.1 Segment scope
1.1.2 Regional scope
1.1.3 Estimates and forecast timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased database:
1.3.2 GVR’s internal database
1.3.3 Secondary sources
1.3.4 Primary research
1.3.5 Details of primary research
1.4 Information or Data Analysis
1.4.1 Data analysis models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis
1.6.1.1 Approach: Commodity Flow Approach
1.7 Research Assumptions
1.8 List of Secondary Sources
1.9 List of Abbreviations
1.10 Objectives
1.10.1 Objective
1.10.2 Objective
1.10.3 Objective
CHAPTER 2 EXECUTIVE SUMMARY
2.1 Market Outlook
CHAPTER 3 PARKINSON’S DISEASE TREATMENT MARKET VARIABLES, TRENDS, AND SCOPE
3.1 Parent Market Outlook
3.1.1 Central Nervous System Therapeutics Market
3.2 Penetration and Growth Prospect Mapping
3.3 Regulatory & Reimbursement Scenario
3.4 Market Driver Analysis
3.4.1 Increasing prevalence of Parkinson’s disease
3.4.2 Presence of strong pipeline drugs
3.4.3 Introduction of novel drug delivery systems
3.5 Market Restraint Analysis
3.5.1 High treatment cost
3.5.2 Lack of neurologist and neurosurgeons
3.6 Major Deals and Strategic Alliances
3.7 Pipeline Analysis
3.8 SWOT Analysis, by Factor (Political & Legal, Economic, and Technological)
3.9 Industry Analysis - Porter’s
CHAPTER 4 PARKINSON’S DISEASE TREATMENT MARKET: COMPETITIVE ANALYSIS
4.1 Recent Developments and Impact Analysis, by Key Market Participants
4.1.1 New Product Launches
4.1.2 Mergers and Acquisitions
4.1.3 Partnerships and Strategic Collaboration
4.1.4 Conferences and Campaigns
4.2 Company Categorization
4.2.1 Innovators
4.2.2 Market Leaders
4.2.3 Heat map analysis
4.3 Vendor Landscape
4.3.1 List of key distributors and channel partners
4.3.2 Key customers
4.4 Key Company Market Share Analysis, 2021
4.5 Public Companies
4.5.1 Company market position analysis
4.5.2 Competitive dashboard analysis
4.5.2.1 Market Differentiators
4.6 Private Companies
4.6.1 List of key emerging companies
4.6.2 Regional Network Map
CHAPTER 5 PARKINSON’S DISEASE TREATMENT MARKET: SEGMENT ANALYSIS, BY DRUG CLASS, 2018 - 2030 (USD MILLION)
5.1 Parkinson’s Disease Treatment Market: Drug Class Movement Analysis
5.2 Carbidopa-Levodopa
5.2.1 Carbidopa-levodopa market, 2018 - 2030 (USD Million)
5.3 Dopamine Agonists
5.3.1 Dopamine agonists market, 2018 - 2030 (USD Million)
5.4 MAO-B Inhibitors
5.4.1 MAO-B inhibitors market, 2018 - 2030 (USD Million)
5.5 COMT inhibitors
5.5.1 COMT inhibitors market, 2018 - 2030 (USD Million)
5.6 Anticholinergics
5.6.1 Anticholinergics market, 2018 - 2030 (USD Million)
5.7 Others
5.7.1 Others market, 2018 - 2030 (USD Million)
CHAPTER 6 PARKINSON’S DISEASE TREATMENT MARKET: SEGMENT ANALYSIS, BY DISTRIBUTION CHANNEL, 2018 - 2030 (USD MILLION)
6.1 Parkinson’s Disease Treatment Market: Distribution Channel Movement Analysis
6.2 Hospital Pharmacy
6.2.1 Hospital pharmacy market, 2018 - 2030 (USD Million)
6.3 Retail Pharmacy
6.3.1 Retail pharmacy market, 2018 - 2030 (USD Million)
6.4 Online Pharmacy
6.4.1 Online pharmacy market, 2018 - 2030 (USD Million)
CHAPTER 7 PARKINSON’S DISEASE TREATMENT MARKET: SEGMENT ANALYSIS, BY REGION, 2018 - 2030 (USD MILLION)
7.1 Definition & Scope
7.2 Regional Market Share Analysis, 2021 & 2030
7.3 Regional Market Snapshot
7.4 Market Size, & Forecasts, Revenue and Trend Analysis, 2021 to 2030
7.4.1 North America
7.4.1.1 North America Parkinson’s disease treatment, 2018-2030 (USD Million)
7.4.1.2 U.S.
7.4.1.2.1 U.S. Parkinson’s disease treatment market, 2018 - 2030 (USD Million)
7.4.1.3 Canada
7.4.1.3.1 Canada Parkinson’s disease treatment market, 2018 - 2030 (USD Million)
7.4.2 Europe
7.4.2.1 Europe Parkinson’s disease treatment market, 2018 - 2030 (USD Million)
7.4.2.2 U.K.
7.4.2.2.1 U.K. Parkinson’s disease treatment market, 2018 - 2030 (USD Million)
7.4.2.3 Germany
7.4.2.3.1 Germany Parkinson’s disease treatment market, 2018 - 2030 (USD Million)
7.4.2.4 Spain
7.4.2.4.1 Spain Parkinson’s disease treatment market, 2018 - 2030 (USD Million)
7.4.2.5 France
7.4.2.5.1 France Parkinson’s disease treatment market, 2018 - 2030 (USD Million)
7.4.2.6 Italy
7.4.2.6.1 Italy Parkinson’s disease treatment market, 2018 - 2030 (USD Million)
7.4.3 Asia Pacific
7.4.3.1 Asia Pacific Parkinson’s disease treatment market, 2018 - 2030 (USD Million)
7.4.3.2 Japan
7.4.3.2.1 Japan Parkinson’s disease treatment market, 2018 - 2030 (USD Million)
7.4.3.3 China
7.4.3.3.1 China Parkinson’s disease treatment market, 2018 - 2030 (USD Million)
7.4.3.4 India
7.4.3.4.1 India Parkinson’s disease treatment market, 2018 - 2030 (USD Million)
7.4.3.5 South Korea
7.4.3.5.1 South Korea Parkinson’s disease treatment market, 2018 - 2030 (USD Million)
7.4.3.6 Australia
7.4.3.6.1 Australia Parkinson’s disease treatment market, 2018 - 2030 (USD Million)
7.4.4 Latin America
7.4.4.1 Latin America Parkinson’s disease treatment market, 2018 - 2030 (USD Million)
7.4.4.2 Brazil
7.4.4.2.1 Brazil Parkinson’s disease treatment market, 2018 - 2030 (USD Million)
7.4.4.3 Mexico
7.4.4.3.1 Mexico Parkinson’s disease treatment market, 2018 - 2030 (USD Million)
7.4.4.4 Argentina
7.4.4.4.1 Argentina Parkinson’s disease treatment market, 2018 - 2030 (USD Million)
7.4.5 MEA
7.4.5.1 MEA Parkinson’s disease treatment market, 2018 - 2030 (USD Million)
7.4.5.2 South Africa
7.4.5.2.1 South Africa Parkinson’s disease treatment market, 2018 - 2030 (USD Million)
7.4.5.3 Saudi Arabia
7.4.5.3.1 Saudi Arabia Parkinson’s disease treatment market, 2018 - 2030 (USD Million)
7.4.5.4 UAE
7.4.5.4.1 UAE Parkinson’s disease treatment market, 2018 - 2030 (USD Million)
CHAPTER 8 PARKINSON’S DISEASE TREATMENT MARKET: COMPANY PROFILES
8.1 Company Profiles
8.1.1 Cerevel Therapeutics
8.1.1.1 Company Overview
8.1.1.2 Financial Performance
8.1.1.3 Product Benchmarking
8.1.1.4 recent Developments
8.1.2 Novartis AG
8.1.2.1 Company Overview
8.1.2.2 Financial Performance
8.1.2.3 Product Benchmarking
8.1.2.4 Recent Developments
8.1.3 Teva Pharmaceutical Industries Ltd
8.1.3.1 Company Overview
8.1.3.2 Financial Performance
8.1.3.3 Product Benchmarking
8.1.3.4 Recent Developments
8.1.4 Merck & Co., Inc.
8.1.4.1 Company Overview
8.1.4.2 Financial Performance
8.1.4.3 Product Benchmarking
8.1.4.4 Recent Developments
8.1.5 GlaxoSmithKline plc. (GSK)
8.1.5.1 Company Overview
8.1.5.2 Financial Performance
8.1.5.3 Product Benchmarking
8.1.5.4 Recent Developments
8.1.6 AbbVie, Inc.
8.1.6.1 Company Overview
8.1.6.2 Financial Performance
8.1.6.3 Product Benchmarking
8.1.6.5 Recent Developments
8.1.7 H. Lundbeck A/S
8.1.7.1 Company Overview
8.1.7.2 Financial Performance
8.1.7.3 Product Benchmarking
8.1.8 Amneal Pharmaceuticals LLC.
8.1.8.1 Company Overview
8.1.8.3 Financial Benchmarking
8.1.8.4 Product Benchmarking
8.1.8.5 Recent Developments
8.1.9 Supernus Pharmaceuticals, Inc.
8.1.9.1 Company Overview
8.1.9.2 Financial performance
8.1.9.3 Product Benchmarking
8.1.9.4 Recent Developments
LIST OF TABLES
Table 1 List of Secondary Sources
Table 2 List of Abbreviation
Table 3 Global Parkinson’s Disease Treatment Market, By Region, 2018 - 2030 (USD Million)
Table 4 Global Parkinson’s Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 5 Global Parkinson’s Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 6 North America Parkinson’s Disease Treatment Market, By Country, 2018 - 2030 (USD Million)
Table 7 North America Parkinson’s Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 8 North America Parkinson’s Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 9 U.S. Parkinson’s Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 10 U.S. Parkinson’s Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 11 Canada Parkinson’s Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 12 Canada Parkinson’s Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 13 Europe Parkinson’s Disease Treatment Market, By Country, 2018 - 2030 (USD Million)
Table 14 Europe Parkinson’s Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 15 Europe Parkinson’s Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 16 Germany Parkinson’s Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 17 Germany Parkinson’s Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 18 U.K. Parkinson’s Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 19 U.K. Parkinson’s Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 20 France Parkinson’s Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 21 France Parkinson’s Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 22 Italy Parkinson’s Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 23 Italy Parkinson’s Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 24 Spain Parkinson’s Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 25 Spain Parkinson’s Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 26 Asia Pacific Parkinson’s Disease Treatment Market, By Country, 2018 - 2030 (USD Million)
Table 27 Asia Pacific Parkinson’s Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 28 Asia Pacific Parkinson’s Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 29 Japan Parkinson’s Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 30 Japan Parkinson’s Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 31 China Parkinson’s Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 32 China Parkinson’s Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 33 India Parkinson’s Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 34 India Parkinson’s Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 35 South Korea Parkinson’s Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 36 South Korea Parkinson’s Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 37 Australia Parkinson’s Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 38 Australia Parkinson’s Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 39 Latin America Parkinson’s Disease Treatment Market, By Country, 2018 - 2030 (USD Million)
Table 40 Latin America Parkinson’s Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 41 Latin America Parkinson’s Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 42 Brazil Parkinson’s Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 43 Brazil Parkinson’s Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 44 Mexico Parkinson’s Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 45 Mexico Parkinson’s Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 46 Argentina Parkinson’s Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 47 Argentina Parkinson’s Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 48 Middle East & Africa Parkinson’s Disease Treatment Market, By Country, 2018 - 2030 (USD Million)
Table 49 Middle East & Africa Parkinson’s Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 50 Middle East & Africa Parkinson’s Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 51 Saudi Arabia Parkinson’s Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 52 Saudi Arabia Parkinson’s Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 53 South Africa Parkinson’s Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 54 South Africa Parkinson’s Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 55 UAE Parkinson’s Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 56 UAE Parkinson’s Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 1 List of Secondary Sources
Table 2 List of Abbreviation
Table 3 Global Parkinson’s Disease Treatment Market, By Region, 2018 - 2030 (USD Million)
Table 4 Global Parkinson’s Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 5 Global Parkinson’s Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 6 North America Parkinson’s Disease Treatment Market, By Country, 2018 - 2030 (USD Million)
Table 7 North America Parkinson’s Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 8 North America Parkinson’s Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 9 U.S. Parkinson’s Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 10 U.S. Parkinson’s Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 11 Canada Parkinson’s Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 12 Canada Parkinson’s Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 13 Europe Parkinson’s Disease Treatment Market, By Country, 2018 - 2030 (USD Million)
Table 14 Europe Parkinson’s Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 15 Europe Parkinson’s Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 16 Germany Parkinson’s Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 17 Germany Parkinson’s Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 18 U.K. Parkinson’s Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 19 U.K. Parkinson’s Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 20 France Parkinson’s Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 21 France Parkinson’s Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 22 Italy Parkinson’s Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 23 Italy Parkinson’s Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 24 Spain Parkinson’s Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 25 Spain Parkinson’s Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 26 Asia Pacific Parkinson’s Disease Treatment Market, By Country, 2018 - 2030 (USD Million)
Table 27 Asia Pacific Parkinson’s Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 28 Asia Pacific Parkinson’s Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 29 Japan Parkinson’s Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 30 Japan Parkinson’s Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 31 China Parkinson’s Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 32 China Parkinson’s Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 33 India Parkinson’s Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 34 India Parkinson’s Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 35 South Korea Parkinson’s Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 36 South Korea Parkinson’s Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 37 Australia Parkinson’s Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 38 Australia Parkinson’s Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 39 Latin America Parkinson’s Disease Treatment Market, By Country, 2018 - 2030 (USD Million)
Table 40 Latin America Parkinson’s Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 41 Latin America Parkinson’s Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 42 Brazil Parkinson’s Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 43 Brazil Parkinson’s Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 44 Mexico Parkinson’s Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 45 Mexico Parkinson’s Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 46 Argentina Parkinson’s Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 47 Argentina Parkinson’s Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 48 Middle East & Africa Parkinson’s Disease Treatment Market, By Country, 2018 - 2030 (USD Million)
Table 49 Middle East & Africa Parkinson’s Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 50 Middle East & Africa Parkinson’s Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 51 Saudi Arabia Parkinson’s Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 52 Saudi Arabia Parkinson’s Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 53 South Africa Parkinson’s Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 54 South Africa Parkinson’s Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 55 UAE Parkinson’s Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 56 UAE Parkinson’s Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
LIST OF FIGURES
Fig. 1 Parkinson’s Disease Treatment Market Segmentation
Fig. 2 Market Research Process
Fig. 3 Information Procurement
Fig. 4 Primary Research Pattern
Fig. 5 Market Research Approaches
Fig. 6 Value-Chain-Based Sizing & Forecasting
Fig. 7 QFD Modeling for Market Share Assessment
Fig. 8 Market Formulation & Validation
Fig. 9 Market Outlook (2021)
Fig. 10 Penetration and Growth Prospect Mapping
Fig. 11 Parkinson’s Disease Treatment Market Driver Impact
Fig. 12 Parkinson’s Disease Treatment Market Restraint Impact
Fig. 13 Major Deals and Strategic Alliances
Fig. 14 SWOT Analysis, By Factor (Political & Legal, Economic, And Technological)
Fig. 15 Porter’s Five Forces Analysis
Fig. 16 Heat Map Analysis
Fig. 17 Company Market Share Analysis (2021)
Fig. 18 Company Market Position Analysis (2021), Revenue Analysis
Fig. 19 Company Market Position Analysis (2021), Profit Margin Analysis
Fig. 20 Market Differentiators
Fig. 21 Regional Network Map
Fig. 22 Parkinson’s Disease Treatment Market Drug Class Outlook: Key Takeaways
Fig. 23 Parkinson’s Disease Treatment Market: Drug Class Movement Analysis
Fig. 24 Carbidopa-Levodopa Market, 2018 - 2030 (USD Million)
Fig. 25 Dopamine Agonist Market, 2018 - 2030 (USD Million)
Fig. 26 MAO-B Inhibitors Market, 2018 - 2030 (USD Million)
Fig. 27 COMT Inhibitors Market, 2018 - 2030 (USD Million)
Fig. 28 Anticholinergics Market, 2018 - 2030 (USD Million)
Fig. 29 Others Market, 2018 - 2030 (USD Million)
Fig. 30 Parkinson’s Disease Treatment Market Distribution Channel Outlook: Key Takeaways
Fig. 31 Parkinson’s Disease Treatment Market: Distribution Channel Movement Analysis
Fig. 32 Hospital Pharmacy Market, 2018 - 2030 (USD Million)
Fig. 33 Retail Pharmacy Market, 2018 - 2030 (USD Million)
Fig. 34 Online Pharmacy Market, 2018 - 2030 (USD Million)
Fig. 35 Regional Outlook, 2020 & 2030
Fig. 36 Regional Marketplace: Key Takeaways
Fig. 37 North America
Fig. 38 North America Parkinson’s Disease Treatment Market, 2018 - 2030 (USD Million)
Fig. 39 U.S.
Fig. 40 U.S. Parkinson’s Disease Treatment Market, 2018 - 2030 (USD Million)
Fig. 41 Canada
Fig. 42 Canada Parkinson’s Disease Treatment Market, 2018 - 2030 (USD Million)
Fig. 43 Europe
Fig. 44 Europe Parkinson’s Disease Treatment Market, 2018 - 2030 (USD Million)
Fig. 45 U.K.
Fig. 46 U.K. Parkinson’s Disease Treatment Market, 2018 - 2030 (USD Million)
Fig. 47 Germany
Fig. 48 Germany Parkinson’s Disease Treatment Market, 2018 - 2030 (USD Million)
Fig. 49 Spain
Fig. 50 Spain Parkinson’s Disease Treatment Market, 2018 - 2030 (USD Million)
Fig. 51 France
Fig. 52 France Parkinson’s Disease Treatment Market, 2018 - 2030 (USD Million)
Fig. 53 Italy
Fig. 54 Italy Parkinson’s Disease Treatment Market, 2018 - 2030 (USD Million)
Fig. 55 Asia Pacific
Fig. 56 Asia Pacific Parkinson’s Disease Treatment Market, 2018 - 2030 (USD Million)
Fig. 57 Japan
Fig. 58 Japan Parkinson’s Disease Treatment Market, 2018 - 2030 (USD Million)
Fig. 59 China
Fig. 60 China Parkinson’s Disease Treatment Market, 2018 - 2030 (USD Million)
Fig. 61 India
Fig. 62 India Parkinson’s Disease Treatment Market, 2018 - 2030 (USD Million)
Fig. 63 South Korea
Fig. 64 South Korea Parkinson’s Disease Treatment Market, 2018 - 2030 (USD Million)
Fig. 65 Australia
Fig. 66 Australia Parkinson’s Disease Treatment Market, 2018 - 2030 (USD Million)
Fig. 67 Latin America
Fig. 68 Latin America Parkinson’s Disease Treatment Market, 2018 - 2030 (USD Million)
Fig. 69 Brazil
Fig. 70 Brazil Parkinson’s Disease Treatment Market, 2018 - 2030 (USD Million)
Fig. 71 Mexico
Fig. 72 Mexico Parkinson’s Disease Treatment Market, 2018 - 2030 (USD Million)
Fig. 73 Argentina
Fig. 74 Argentina Parkinson’s Disease Treatment Market, 2018 - 2030 (USD Million)
Fig. 75 Middle East and Africa
Fig. 76 MEA Parkinson’s Disease Treatment Market, 2018 - 2030 (USD Million)
Fig. 77 South Africa
Fig. 78 South Africa Parkinson’s Disease Treatment Market, 2018 - 2030 (USD Million)
Fig. 79 Saudi Arabia
Fig. 80 Saudi Arabia Parkinson’s Disease Treatment Market, 2018 - 2030 (USD Million)
Fig. 81 UAE
Fig. 82 UAE Parkinson’s Disease Treatment Market, 2018 - 2030 (USD Million)
Fig. 1 Parkinson’s Disease Treatment Market Segmentation
Fig. 2 Market Research Process
Fig. 3 Information Procurement
Fig. 4 Primary Research Pattern
Fig. 5 Market Research Approaches
Fig. 6 Value-Chain-Based Sizing & Forecasting
Fig. 7 QFD Modeling for Market Share Assessment
Fig. 8 Market Formulation & Validation
Fig. 9 Market Outlook (2021)
Fig. 10 Penetration and Growth Prospect Mapping
Fig. 11 Parkinson’s Disease Treatment Market Driver Impact
Fig. 12 Parkinson’s Disease Treatment Market Restraint Impact
Fig. 13 Major Deals and Strategic Alliances
Fig. 14 SWOT Analysis, By Factor (Political & Legal, Economic, And Technological)
Fig. 15 Porter’s Five Forces Analysis
Fig. 16 Heat Map Analysis
Fig. 17 Company Market Share Analysis (2021)
Fig. 18 Company Market Position Analysis (2021), Revenue Analysis
Fig. 19 Company Market Position Analysis (2021), Profit Margin Analysis
Fig. 20 Market Differentiators
Fig. 21 Regional Network Map
Fig. 22 Parkinson’s Disease Treatment Market Drug Class Outlook: Key Takeaways
Fig. 23 Parkinson’s Disease Treatment Market: Drug Class Movement Analysis
Fig. 24 Carbidopa-Levodopa Market, 2018 - 2030 (USD Million)
Fig. 25 Dopamine Agonist Market, 2018 - 2030 (USD Million)
Fig. 26 MAO-B Inhibitors Market, 2018 - 2030 (USD Million)
Fig. 27 COMT Inhibitors Market, 2018 - 2030 (USD Million)
Fig. 28 Anticholinergics Market, 2018 - 2030 (USD Million)
Fig. 29 Others Market, 2018 - 2030 (USD Million)
Fig. 30 Parkinson’s Disease Treatment Market Distribution Channel Outlook: Key Takeaways
Fig. 31 Parkinson’s Disease Treatment Market: Distribution Channel Movement Analysis
Fig. 32 Hospital Pharmacy Market, 2018 - 2030 (USD Million)
Fig. 33 Retail Pharmacy Market, 2018 - 2030 (USD Million)
Fig. 34 Online Pharmacy Market, 2018 - 2030 (USD Million)
Fig. 35 Regional Outlook, 2020 & 2030
Fig. 36 Regional Marketplace: Key Takeaways
Fig. 37 North America
Fig. 38 North America Parkinson’s Disease Treatment Market, 2018 - 2030 (USD Million)
Fig. 39 U.S.
Fig. 40 U.S. Parkinson’s Disease Treatment Market, 2018 - 2030 (USD Million)
Fig. 41 Canada
Fig. 42 Canada Parkinson’s Disease Treatment Market, 2018 - 2030 (USD Million)
Fig. 43 Europe
Fig. 44 Europe Parkinson’s Disease Treatment Market, 2018 - 2030 (USD Million)
Fig. 45 U.K.
Fig. 46 U.K. Parkinson’s Disease Treatment Market, 2018 - 2030 (USD Million)
Fig. 47 Germany
Fig. 48 Germany Parkinson’s Disease Treatment Market, 2018 - 2030 (USD Million)
Fig. 49 Spain
Fig. 50 Spain Parkinson’s Disease Treatment Market, 2018 - 2030 (USD Million)
Fig. 51 France
Fig. 52 France Parkinson’s Disease Treatment Market, 2018 - 2030 (USD Million)
Fig. 53 Italy
Fig. 54 Italy Parkinson’s Disease Treatment Market, 2018 - 2030 (USD Million)
Fig. 55 Asia Pacific
Fig. 56 Asia Pacific Parkinson’s Disease Treatment Market, 2018 - 2030 (USD Million)
Fig. 57 Japan
Fig. 58 Japan Parkinson’s Disease Treatment Market, 2018 - 2030 (USD Million)
Fig. 59 China
Fig. 60 China Parkinson’s Disease Treatment Market, 2018 - 2030 (USD Million)
Fig. 61 India
Fig. 62 India Parkinson’s Disease Treatment Market, 2018 - 2030 (USD Million)
Fig. 63 South Korea
Fig. 64 South Korea Parkinson’s Disease Treatment Market, 2018 - 2030 (USD Million)
Fig. 65 Australia
Fig. 66 Australia Parkinson’s Disease Treatment Market, 2018 - 2030 (USD Million)
Fig. 67 Latin America
Fig. 68 Latin America Parkinson’s Disease Treatment Market, 2018 - 2030 (USD Million)
Fig. 69 Brazil
Fig. 70 Brazil Parkinson’s Disease Treatment Market, 2018 - 2030 (USD Million)
Fig. 71 Mexico
Fig. 72 Mexico Parkinson’s Disease Treatment Market, 2018 - 2030 (USD Million)
Fig. 73 Argentina
Fig. 74 Argentina Parkinson’s Disease Treatment Market, 2018 - 2030 (USD Million)
Fig. 75 Middle East and Africa
Fig. 76 MEA Parkinson’s Disease Treatment Market, 2018 - 2030 (USD Million)
Fig. 77 South Africa
Fig. 78 South Africa Parkinson’s Disease Treatment Market, 2018 - 2030 (USD Million)
Fig. 79 Saudi Arabia
Fig. 80 Saudi Arabia Parkinson’s Disease Treatment Market, 2018 - 2030 (USD Million)
Fig. 81 UAE
Fig. 82 UAE Parkinson’s Disease Treatment Market, 2018 - 2030 (USD Million)
